In a study on human skin cancers, Syndecan-1 (SDC1) expression was reduced in squamous cell carcinoma, basal cell carcinoma, as well as metastatic adenocarcinomas [72], and the downregulated expression of this protein may be indicative of reduced lipid metabolism in melanoma [73]. This evidence concerns the gene SDC1 and basal cell carcinoma.